Loading interactive chart. Forums. ASX - Day TradingIXC: 22/11/2023 1:08 PM : Notification of cessation of securities - IXC 4 pages 23. ASX - General. That is fair and as I mentioned in my initial post when buying, the business is worth the cash in ST. IXC below Example of that is NEU Investor Presentation, page-3. Invex Granted Type C Meeting with FDA, page-3. Created with Sketch. , page-75. Ceasing to be a substantial holderAustralian finance news, stock quotes, currency information and blogsQuarterly Activities/Appendix 4C Cash Flow ReportInvex Granted European Patent for Exenatide in Hydrocephalus. I see it at perhaps $5 prior to readout. 5% last year. Information. Both approaches can work, but it is not wise to confuse the two. 9MB OEC: 22/11/2023 1:05 PM : Cleansing Notice 2 pages 172. HotCopper has news, discussion, prices and market data on IXUP LIMITED. **Close price adjusted for splits and dividend and/or capital gain distributions. Just unfortunate to hit the black swan so badly here, both the. LATEST NEWS: Toubani Resources releases MRE update for Kobada gold project, Mali. 40. 0. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. Market . Join the HotCopper ASX share market forum today for free. Charts. Created with Sketch. ASX - By Stock. Latest Posts. Below is the broker data for IXC November to. Notification of cessation of securities - IXC. ASX - Day TradingIf IXC is positioning itself as a takeover target and the trial endpoints allow for it, it would make sense to provide early readouts. Mernova, a subsidiary of Melodiol Global Health (ASX:ME1), is on track to achieve its highest ever monthly sales, with revenues expected to reach A$891,944 in October 2023. ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportA new thread to put trading comments / reasoning / opinions in. Last research or update on this I listened to was by FiftyOneCapital. All IMO IXC Price at posting: 37. As thread states post your questions here and let’s start compiling a list. Invex Therapeutics Lists on ASXNo worries mate :), page-15. . Investor PresentationInvex Successfully Concludes Protocol Assistance with EMACreated with Sketch. ASX - Day TradingCreated with Sketch. boolish Jellyroll hey. Australia's largest stock trading and investment forum Australia's #1 stock forumInvestor PresentationMRDMount Ridley Mines REE Project: Drilling confirms continuous high-grade mineralisation. Thought that this would be worthy of its own thread, a great starting place for those new to IXC and arguably the best presentation to date, Worth a. 7KB AVG: 22/11/2023 1:08 PM : 2023 AVG AGM Addresses and Presentation 35 pages 3. . 50%. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. We are supported by a Board of Advice which is made up of the premier leaders in the various fields in which we, Private Capital Advisers, specialise. How many friends and family got out after the last announcementshould have been released at the same time, page-34. ASX - Short Term Trading. ASX - Day TradingNotice of Webinar &amp; Investor PresentationCreated with Sketch. GW Ixc once again showing why you are the best mgmt team on the ASX . pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. is there any news release, or SP increasing due to only the market showing interest, page-2. . ASX - Short Term Trading. , page-4. Join the HotCopper ASX share market forum today for free. Loading. Created with Sketch. You are the controller for IXC, you call the shots to make the company as best as possible for shareholders - this means retaining talent and forwarding the company to Phase III success and beyond. . Created with Sketch. 31% more bullish than other Healthcare sector stocks. Commodities. Australia's largest stock trading and investment forum Australia's #1 stock forumIXC peaked at $1. ASX - By Stock. Just another way to saying that we've got Patient 1 out of 240. Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. ASX - Short Term Trading. Share Not unexpected. . Quarterly Activities/Appendix 4C Cash Flow Report. ASX - Day TradingMEDSAFE and Ethics Approval for IIH EVOLVE Trial in NZCreated with Sketch. ASX - Day TradingCreated with Sketch. If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. 5¢ Sentiment: Buy Disclosure: Held. IXC Valuation Report MST. IXC is at base, so it’s just a matter of when it’ll leave base and start turning to the upside. Market . Forex. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Plans & Pricing. Australia's largest stock trading and investment forum Australia's #1 stock forumInvex Successfully Concludes Protocol Assistance with EMA, page-2. Wouldn’t surprised me if they turn this company into something else if he keeps buyingCreated with Sketch. 0¢ Sentiment: Buy Disclosure: HeldHotCopper has news, discussion, prices and market data on GENESIS MINERALS LIMITED. Created with Sketch. . ASX - By Stock. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. Expand. Of course, IXC’s BoD need to win back credibility for the market to more fairly value IXC’s TBI ODD… Having gone through the roller-coaster over the past one week, with my emotions now settled – I will be (slowly) buying-up in. Re-purposed FDA drug for other illness with amazing effect as domenstrated in P2 results which ever drove sp to $2. , page-3. ASX - Day TradingInitial FDA and EMA Advice on Presendin Development, page-2. 30 Haven’t supported share price since then on market . A new thread to put trading comments / reasoning / opinions in. Anyone buying now can carry to $5 and then sell a few prior to readout as insurance against losing everything in the coin flip. ASX - Short Term Trading. Target our investor community with our suite of Hotcopper Advertising. Postcard to ShareholdersIXC (ASX) Ann: Trading Halt - HotCopper. These are 2007 numbers. . I guess that&amp;apos;s why retail performs so poorly on average, so many think they are long term investors but can&amp;apos;t hold onto their shares for more. 05. Charts. Created with Sketch. IXC Valuation Report MST. ASX - Day TradingSomeone bought $500 stock today at 44 cents. Last updated 15. AdINVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC. . 64440. 9 more clinical sites to be rapidly activated in a country with a growing incidence of IIH cases. Get the edge as an investor: Subscribe to our daily newsletter for EXCLUSIVE insights into HotCopper!. I think having this out we can discuss on the way. 59 before first real pull back (those lines will be used in the future, they always set it up for that reason, being $3. ASX - By Stock. ASX - Day Trading. Join the HotCopper ASX share market forum today for free. 5¢ Sentiment: Buy Disclosure: HeldAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. . ASX - By Stock. 1. Latest Posts. Andrew Forrest , or his entities have been involved with IXC since inception. . . . Will management look for an early exit or are they wanting to take to market? Just came across IXC from another stock @JabraD posts on. The IXC stock may trade low due to this wider macroeconomic issues, but the business itself is top 5% to its peers merely from the fact of having no future funding requirements and that if the trial is a success having close to immediate revenues and default alive status via Peptron manufacturing contract fulfilling demand on potential FDA. Forums. IXC Valuation Report MST. Consequently, this would result in faster market penetration and an accelerated timeline to peak sales. I bought the chart from base lows looking for a trade. . I find this very intriguing and positive that in last few weeks about 1. . IXC on the other hand with nearer catalysts has already done its basing cycle Of course different stock different TAMS etc etc, probably why IMU is worth 640 mill MC and IXC 28 mill MC But again its why IXC is offering so much more in terms of value atm plus risk v reward All IMO of course, but yeh maybe some IMU investors pop across. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure. The Phase III raise encompassed the costs for a go-it-alone reformulation strategy, with Bell Potter suggesting in a Q&A with IXC that they saved $5-6M in going with Peptron for their reformulation supply/manufacturing, alongside 12 months in time. 0¢ Sentiment: Buy Disclosure: Held Created with Sketch. They have acted appropriately. But there are two key factors that make me hope that the BoD pursues the Phase 2, but I worry that JP and co will push for the. sentiment based on opinions from HotCopper and others. I'm topping up. ASX - Day Trading. Charts. RAC went from 30 cents to $4 in the space of 5 months PAR went from 30 cents to $4 in the space of 1 and half years NEU went from $1. Invex to Present at Upcoming Tech Biotech Broker BriefingCreated with Sketch. Chairman's Address to Shareholders and PresentationHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. ASX - By Stock. ASX - Day Trading It is certainly an interesting case study regarding management strategy; that noted strategy would work during fair or bullish markets as participants are acting rationally (and by sticking to their knitting during Covid Crash the IXC share price bounced back heavily with Phase II results - so perhaps thats what they were thinking would happen. Join the HotCopper ASX share market forum today for free. . Market Wrap - Top 3 Gainers #ASXGainers: $IXC 54. 50%. HotCopper has news, discussion, prices and market data on IONIC RARE EARTHS LIMITED. Created with Sketch. . The Calmer Co (ASX:CCO) breaks new ground in Australian Retail with Kava shots to launch in Coles from January 2024Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. . . 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. , page-3. Probably been disappointed like all of us Created with Sketch. Although, IXC is trading about 3-4x lower than what I expect it to be. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. . IXC Price at posting:. 26 area could be wrong and it could go for example to $3. Commodities. My understanding is that NEU went from around $1. Not sure what software this is but is there a way you can send the document itself, is a tad tough to read it with the photo you sent, if not all good, page-4. Created with Sketch. Created with Sketch. Invex Files Pre-IND/Type B Meeting Request with US FDAIXC is a long term play mate, not a daytraders plaything as too illiquid. Latest Posts. . Hopefully that placement overhang will be removed today tomorrow and the share price will catch up. com. 2. Market . Advertise on HotCopper. I think having this out we can discuss on the way. Hi Hot Copper, this will be a master thread for my daily posting of the Pharma Market Watchlist, please only keep commentary to the watchlist. Discover historical prices for IXC. Share No great change in the top 2 big boys who hold 17% of the company, Twiggy's fund unchanged. 59). Here come the vultures. ASX - General. ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. ASX - By Stock. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. ASX - Short Term Trading. Created with Sketch. . . ASX - Short Term Trading. 3. This is a complete waste of time and posting space - give yourself a break man and forget about trying to predict what is completely un-predictable. Invex Therapeutics Limited (ASX:IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure, such as Idiopathic Intracranial Hypertension (IIH), acute stroke and traumatic brain injury. rights. IXC below Example of that is NEUInvestor Presentation, page-3. 3¢. A handy 10 bags from here with seemingly little risk. Latest Posts ForumsHalf Yearly Report and AccountsLooks like people are starting to wake up here and realise how bloody cheap IXC is. . 2 years ago biotech stocks were in vogue and hence NEU was fairly priced at $1. Created with Sketch. , page-5. , page-2. 1950. HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-3. 5¢ Sentiment: Buy Disclosure: Held Created with Sketch. Most bio's get. ASX - By Stock. 6% $DLM 50. Maybe more common that what people think, imagine once GPs start diagnosing it even better if a treatment is developed, Prevalence could increase 2 or times which ultimately increases. . Created with Sketch. Grabbed my first ever parcel in IXC yesterdy at 80c. ASX - Day Trading. Created with Sketch. 1. Join the HotCopper ASX share market forum today for free. . Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. 5mill options have been issued at a strike price of $1 First lot 250k to a soph. 79 -0. Forums. Advertise on HotCopper. , page-5. . Forums. ASX - Day Tradingis invex releasing 2. Very tempted to buy them back today at 19c. But the market volume was very low, which points to a lack of interest, the long horizons of biotech, lack of publicising or Notification of cessation of securities - IXC. Created with Sketch. . Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Anyone had a look at this or put an application in for some stock in the IPO?Created with Sketch. AX stock on Yahoo Finance. Latest Posts. , page-5. Market . , page-4. Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumIXC need to hold a conference call to discuss the announcement - they need to front up. (IXC) - see HotCopper and other bloggers' predictions - TipRanks. , page-6. you post every single trade that is a sell onto Hotcopper. Hopefully they hit the miracle, at least I get something back from this if it goes balls up which in the bio world at the moment is highly likely. Both approaches can work, but it is not wise to confuse the two. . For IXC I see the risk in one indication, comparatively lower TAM than others and different formulation for a week duration while phase II used daily. Trading HaltDCF Valuation: IXC Intrinsic Value of $6. Created with Sketch. ASX - By Stock. Release Date: 20/03/23 08:11; Summary: German Approval for IIH EVOLVE Phase 3 Clinical Trial; Price Sensitive: Yes; Download Document 195. Created with Sketch. ASX - By Stock. 0. June 29 (Reuters) - Invex Therapeutics Ltd (IXC) : INVEX RECEIVES UK APPROVAL TO COMMENCE PHASE III TRIAL CLINICAL TRIAL FOR PRESENDIN DRUG FOR. . I'm talking about the period of the announcement about trials None of them moved apart from retailers that hosed out over 3 mill in shares. Been. Interested to hear that Scott believes the company didn't have the phase 2 data for the initial meeting with FDA/EMA. ASX - By Stock. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. We are a team of expert financial advisers each specialising in different, yet complementary areas. Trading HaltIXC Valuation Report MST. IXC Valuation Report MST. Share IXC needs to be proactive and release a statement. ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Webinvest Pty Ltd<Olsb Unit A/C>. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-7. Market . . 91%) As of 03:35PM EST. Fully funded. 19 Per share (Personal Estimate) vs MST Research report of $3. 38 was the valuation MST gave IXC 9 months ago Considering we are now even further de-risked, getting to the end result, wonder what MST valuation would be now. Appreciate your input Dr T. Global Phase 3 Trial of Presendin to Launch in Q4 2021Invex receives IND approvalInvex Receives Written Response from FDA on Type C Meeting, page-2. ASX - Day TradingChange in substantial holding. 15M !Invex to Present at Bell Potter Healthcare ConferenceNotice of Annual General Meeting/Proxy Form, page-3. The Phase III raise encompassed the costs for a go-it-alone reformulation strategy, with Bell Potter suggesting in a Q&A with IXC that they saved $5-6M in going with Peptron for their reformulation supply/manufacturing, alongside 12 months in time. Charts. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-7. . 5¢ Sentiment: Hold Disclosure: Held IXC Valuation Report MST. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. . Market . Target our investor community with our suite of Hotcopper Advertising opportunities. IXC Price at posting: 37. Invex Therapeutics Ltd. ASX - Day Trading. Forums. Created with Sketch. 0% $ODM 35. Therefore Id bet the same bet with the same info again. Forums. 00% 21. If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. Latest Posts. What would you like to pay the world leader in IIH science as CSO, and how much of that salary you would expect to be spent on market to buy shares? Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only a handful of posts discussing the fundamental analysis of the business itself, Publication of Invex IIH Phase II Pressure Trial Results. IXC (ASX) Ann: Trading Halt - HotCopper. 8 Upvote Created with Sketch. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. 0. ASX - Day Trading. Created with Sketch. Last updated 10. Join the HotCopper ASX share market forum today. 20. 1950. Notice of Investor Call and Presentation, page-3. , page-2. ASX - By Stock. Forums. Friday we moved 55% off 690k volume. Results are our big catalyst Other catalysts include: - new indication - directors buying - half way through trial (120 patients recruited)At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Forex. ASX - Day Trading. EGREcoGraf partners with VinES Energy for pioneering Battery Anode Material Facility in Vietnam. ASX - General. ASX - General. Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. Initial FDA and EMA Advice on Presendin Development, page-3. Only took that large seller to sell, now liquidity has dried up and. . Share Well this is unexpected, for the first time ever for Invex, a director has purchased shares on-market. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Bumping up this thread as $3. . Discover historical prices for IXC. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. Created with Sketch. Invex Files Pre-IND/Type B Meeting Request with US FDA IXC is a long term play mate, not a daytraders plaything as too illiquid. At that time the total costs of IIH exceeded $444,000,000. Also took placement stock @$1. Invex Granted Key European Patent for Exenatide, page-2. Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-2. . Market Wrap - Top 3 Gainers #ASXGainers: $IXC 54. Invex Receives Approval for Paediatric Plan from the EMA, page-3. ASX - Day TradingI bought some today at 44. I'm doing my bit lolRecent success of NEU and ALA just goes to show there is money floating around, all IXC needs is a. ASX - By Stock. Australia's largest stock trading and investment forum Australia's #1 stock forumMay 18 (Reuters) - Invex Therapeutics Ltd (IXC) : INVEX THERAPEUTICS SEEKS TRADING HALT PENDING RELEASE ON RESULTS OF ITS PHASE II TRIAL & UNDERTAKING A. , page-20. 6% $DLM 50. ASX. Notification of cessation of securities - IXC. Invex Therapeutics Ltd. I think having this out we can discuss on the way. Spot on - filled the 1. Australia's largest stock trading and investment forum Australia's #1 stock forumCreated with Sketch.